MedTrace Logo

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction

NCT03834610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2019-02-08

No results posted yet for this study

Summary

Tadalafil is an effective oral therapy in erectile dysfunction. L-arginine is a pro drug that increase the level of nitrous oxide in the smooth muscles so can increase the strength and duration of erection. this clinical trials compare the daily oral L-arginine plus tadalafil in treatment of erectile dysfunction in diabetic patients.

Conditions

Interventions

DRUG

L-arginine 5 gm oral caps

oral L-arginine 5 gm daily for 8 weeks

DRUG

Tadalafil 10 MG

oral daily tadalafil 10mg for 8 weeks

DIAGNOSTIC_TEST

serum testosterone level

measurement of serum testosterone level

DIAGNOSTIC_TEST

HbA1C

measurement of HbA1C levels

DEVICE

penile doppler

penile doppler to measure the degree of erection and penile vasculature

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Principal Investigators

  • Moustafa M El Taieb, MD · Aswan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
56 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-10-01
Completion
2018-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834610 on ClinicalTrials.gov